NEWCELX LTD.

Profile

Company Names

NEWCELX LTD.
NLS PHARMACEUTICS LTD.

Addresses

HOHSTRASSE 1, KLOTEN, V8 8302

THE CIRCLE 6, ZURICH, V8 CH-8058

THE CIRCLE 6, 8058, ZURICH, V8 CH-6370

Phone Numbers

41 44 512 21 50
41.44.512.2150
+41-44-512-2150

 

Entity Type:

OTHER

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

SWITZERLAND

Total Amount Raised:

$30,665,648.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2026-04-27 
$3,428,989.00 
$3,428,989.00 
$0.00 
Equity 
8
2025-06-27 
$1,000,000.00 
$1,000,000.00 
$0.00 
Equity 
7
2025-03-28 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
6
2025-01-07 
$499,999.00 
$499,999.00 
$0.00 
Equity 
5
2024-10-11 
$7,200,000.00 
$7,200,000.00 
$0.00 
Equity 
4
2024-06-28 
$786,660.00 
$786,660.00 
$0.00 
Equity 
3
2024-03-20 
$1,750,000.00 
$1,750,000.00 
$0.00 
Equity 
2
2022-12-13 
$10,000,000.00 
$30,000,000.00 
$20,000,000.00 
Equity 
1
2022-10-07 
$4,000,000.00 
$4,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FLORENCE 
ALLOUCHE 
AKNIN 
DIRECTOR
NLS PHARMACEUTICS LTD.
FLORENCE 
 
ALLOUCHE AKNIN 
DIRECTOR
NLS PHARMACEUTICS LTD.
GEORGE 
 
APOSTOL 
EXECUTIVE OFFICER
NLS PHARMACEUTICS LTD.
CLAUDIO 
L.A. 
BASSETI 
DIRECTOR
NLS PHARMACEUTICS LTD.
CLAUDIO 
L. A. 
BASSETTI 
DIRECTOR
NLS PHARMACEUTICS LTD.
CLAUDIO 
L.A. 
BASSETTI 
DIRECTOR
NLS PHARMACEUTICS LTD.
NICOLE 
 
FERNANDEZ-MCGOVERN 
EXECUTIVE OFFICER
AGEAGLE AERIAL SYSTEMS INC.   |  NLS PHARMACEUTICS LTD.
TAMAR 
 
GALILI 
DIRECTOR
NEWCELX LTD.
AUDREY 
 
GREENBERG 
DIRECTOR
NLS PHARMACEUTICS LTD.
RONALD 
 
HAFNER 
DIRECTOR
NLS PHARMACEUTICS LTD.
OMRI 
 
HAGAI 
EXECUTIVE OFFICER, DIRECTOR
SAVERONE 2014 LTD.   |  NEWCELX LTD.
CHAD 
 
HELLMANN 
EXECUTIVE OFFICER
NLS PHARMACEUTICS LTD.
ERAN 
 
IOHAN 
DIRECTOR
NEWCELX LTD.
ERIC 
 
KONOFAL 
EXECUTIVE OFFICER
NLS PHARMACEUTICS LTD.
MYOUNG-OK 
 
KWON 
DIRECTOR
TRACON PHARMACEUTICALS INC   |  NLS PHARMACEUTICS LTD.
KFIR 
 
MOLAKANDOV 
EXECUTIVE OFFICER, DIRECTOR
NEWCELX LTD.
LIORA 
 
OREN 
DIRECTOR
NEWCELX LTD.
STIG LOKKE 
 
PEDERSEN 
DIRECTOR
NLS PHARMACEUTICS LTD.
MICHEL 
 
REVEL 
EXECUTIVE OFFICER, DIRECTOR
NEWCELX LTD.
GIAN-MARCO 
 
RINALDI 
DIRECTOR
NLS PHARMACEUTICS LTD.
GIAN-MARCO 
 
RINALDI DE LA CRUZ 
DIRECTOR
NLS PHARMACEUTICS LTD.
OLIVIER 
 
SAMUEL 
DIRECTOR
NLS PHARMACEUTICS LTD.   |  NEWCELX LTD.
ELENA 
 
THYEN-PIGHIN 
EXECUTIVE OFFICER
NLS PHARMACEUTICS LTD.
RONEN 
 
TWITO 
EXECUTIVE OFFICER, DIRECTOR
NEWCELX LTD.
ANTHONY 
 
WALSH 
DIRECTOR
QUEENSLAND MINERALS LTD.   |  DUNAV RESOURCES LTD.   |  QUATERRA RESOURCES INC   |  PONDFIELD CAPITAL ADVANTAGE, LP   |  DUNDEE PRECIOUS METALS INC   |  GREAT HEIGHTS INC   |  SABINA GOLD + SILVER CORP.   |  NLS PHARMACEUTICS LTD.
ALEXANDER 
 
ZWYER 
EXECUTIVE OFFICER, DIRECTOR
NLS PHARMACEUTICS LTD.
ALEXANDER 
C. 
ZWYER 
EXECUTIVE OFFICER, DIRECTOR
NEWCELX LTD.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-05-13
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-27 
2025-07-10
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-27 
2025-04-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-03-28 
2025-01-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-01-07 
2024-10-21
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-10-11 
2024-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-06-28 
2024-04-03
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-03-20 
2022-12-21
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-12-13 
2022-10-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-10-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
000000375
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037